Market Tracker

04/24 6:59am ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

7.59
Data as of Apr 23
 -0.24 / -3.07%
Today’s Change
5.68
Today|||52-Week Range
18.18
-49.37%
Year-to-Date

Today’s Trading

Previous close7.83
Today’s open7.78
Day’s range-- - --
Volume1,292,352
Average volume (3 months)2,374,247
Market cap$932.4M
Dividend yield--
Data as of 04/23/2014

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+32.53%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc-0.14-3.25%
SZYMSolazyme Inc-0.12-1.04%
OPHTOphthotech Corp+0.18+0.52%
FMIFoundation Medicine ...-1.27-4.56%
Data as of 04/23/2014

Financials

Next reporting dateMay 9, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts